ProFund Advisors »

Bridgebio Oncology Therapeut shares owned by ProFund Advisors

Quarter-by-quarter ownership of Bridgebio Oncology Therapeut (BBOT) shares owned by ProFund Advisors from 13F filings

Historical chart of ProFund Advisors investment in Bridgebio Oncology Therapeut

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Oncology Therapeut held by ProFund Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Oncology Therapeut by ProFund Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $84k 11k 7.62

More positions owned by ProFund Advisors

NVIDIA Corporation (NVDA)
Micron Technology (MU)
Broadcom (AVGO)
Apple (AAPL)
Advanced Micro Devices (AMD)
Microsoft Corporation (MSFT)
Intel Corporation (INTC)
Amazon (AMZN)
Applied Materials (AMAT)
Lam Research Corp Com New (LRCX)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Kla Corp Com New (KLAC)

View all positions for ProFund Advisors

Top funds holding Bridgebio Oncology Therapeut

Cormorant Asset Management
Deerfield Management Company
Omega Fund Management
Alphabet
EcoR1 Capital
Wellington Management Company
Enavate Sciences GP
Citadel Advisors
Novo A/S
BlackRock
Laurion Capital Management
Armistice Capital
Aisling Capital Management
Paradigm Biocapital Advisors
Octagon Capital Advisors

View all funds holding Bridgebio Oncology Therapeut